Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
Sci-Sat AM(2): Brachy-07: Tomosynthesis-based seed reconstruction in LDR prostate brachytherapy: A clinical study.

Medical physics

Brunet-Benkhoucha M, Verhaegen F, Lassalle S, Béliveau-Nadeau D, Reniers B, Donath D, Taussky D, Carrier JF.
PMID: 28512882
Med Phys. 2008 Jul;35(7):3417. doi: 10.1118/1.2965999.

To develop a tomosynthesis-based dose assessment procedure that can be performed after an I-125 prostate seed implantation, while the patient is still under anaesthesia on the treatment table. Our seed detection procedure involves the reconstruction of a volume of...

Cite
Brunet-Benkhoucha M, Verhaegen F, Lassalle S, et al. Sci-Sat AM(2): Brachy-07: Tomosynthesis-based seed reconstruction in LDR prostate brachytherapy: A clinical study. Med Phys. 2008;35(7):3417doi: 10.1118/1.2965999.
Brunet-Benkhoucha, M., Verhaegen, F., Lassalle, S., Béliveau-Nadeau, D., Reniers, B., Donath, D., Taussky, D., & Carrier, J. F. (2008). Sci-Sat AM(2): Brachy-07: Tomosynthesis-based seed reconstruction in LDR prostate brachytherapy: A clinical study. Medical physics, 35(7), 3417. https://doi.org/10.1118/1.2965999
Brunet-Benkhoucha, M, et al. "Sci-Sat AM(2): Brachy-07: Tomosynthesis-based seed reconstruction in LDR prostate brachytherapy: A clinical study." Medical physics vol. 35,7 (2008): 3417. doi: https://doi.org/10.1118/1.2965999
Brunet-Benkhoucha M, Verhaegen F, Lassalle S, Béliveau-Nadeau D, Reniers B, Donath D, Taussky D, Carrier JF. Sci-Sat AM(2): Brachy-07: Tomosynthesis-based seed reconstruction in LDR prostate brachytherapy: A clinical study. Med Phys. 2008 Jul;35(7):3417. doi: 10.1118/1.2965999. PMID: 28512882.
Copy Download .nbib Format: NLM
Fusion of Intraoperative Transrectal Ultrasound Images with Post-implant Computed Tomography and Magnetic Resonance Imaging.

Cureus

Delouya G, Carrier JF, Xavier-Larouche R, Hervieux Y, Béliveau-Nadeau D, Donath D, Taussky D.
PMID: 29850389
Cureus. 2018 Mar 29;10(3):e2394. doi: 10.7759/cureus.2394.

Purpose To compare the impact of the fusion of intraoperative transrectal ultrasound (TRUS) images with day 30 computed tomography (CT) and magnetic resonance imaging (MRI) on prostate volume and dosimetry. Methods and materials Seventy-five consecutive patients with CT and...

Cite
Delouya G, Carrier JF, Xavier-Larouche R, et al. Fusion of Intraoperative Transrectal Ultrasound Images with Post-implant Computed Tomography and Magnetic Resonance Imaging. Cureus. 2018;10(3):e2394doi: 10.7759/cureus.2394.
Delouya, G., Carrier, J. F., Xavier-Larouche, R., Hervieux, Y., Béliveau-Nadeau, D., Donath, D., & Taussky, D. (2018). Fusion of Intraoperative Transrectal Ultrasound Images with Post-implant Computed Tomography and Magnetic Resonance Imaging. Cureus, 10(3), e2394. https://doi.org/10.7759/cureus.2394
Delouya, Guila, et al. "Fusion of Intraoperative Transrectal Ultrasound Images with Post-implant Computed Tomography and Magnetic Resonance Imaging." Cureus vol. 10,3 (2018): e2394. doi: https://doi.org/10.7759/cureus.2394
Delouya G, Carrier JF, Xavier-Larouche R, Hervieux Y, Béliveau-Nadeau D, Donath D, Taussky D. Fusion of Intraoperative Transrectal Ultrasound Images with Post-implant Computed Tomography and Magnetic Resonance Imaging. Cureus. 2018 Mar 29;10(3):e2394. doi: 10.7759/cureus.2394. PMID: 29850389; PMCID: PMC5973483.
Copy Download .nbib Format: NLM
Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Grajales D, Kadoury S, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Le WT, Benhacene-Boudam MK, Juneau D, DaSilva JN, Carrier JF, Hautvast G, Ménard C.
PMID: 34861267
Radiother Oncol. 2021 Nov 30;166:154-161. doi: 10.1016/j.radonc.2021.11.026. Epub 2021 Nov 30.

BACKGROUND AND PURPOSE: Advances in high-dose-rate brachytherapy to treat prostate cancer hinge on improved accuracy in navigation and targeting while optimizing a streamlined workflow. Multimodal image registration and electromagnetic (EM) tracking are two technologies integrated into a prototype system...

Cite
Grajales D, Kadoury S, Shams R, et al. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021;166:154-161doi: 10.1016/j.radonc.2021.11.026.
Grajales, D., Kadoury, S., Shams, R., Barkati, M., Delouya, G., Béliveau-Nadeau, D., Nicolas, B., Le, W. T., Benhacene-Boudam, M. K., Juneau, D., DaSilva, J. N., Carrier, J. F., Hautvast, G., & Ménard, C. (2021). Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 166154-161. https://doi.org/10.1016/j.radonc.2021.11.026
Grajales, David, et al. "Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 166 (2021): 154-161. doi: https://doi.org/10.1016/j.radonc.2021.11.026
Grajales D, Kadoury S, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Le WT, Benhacene-Boudam MK, Juneau D, DaSilva JN, Carrier JF, Hautvast G, Ménard C. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021 Nov 30;166:154-161. doi: 10.1016/j.radonc.2021.11.026. Epub 2021 Nov 30. PMID: 34861267.
Copy Download .nbib Format: NLM
Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Grajales D, Kadoury S, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Le WT, Benhacene-Boudam MK, Juneau D, DaSilva JN, Carrier JF, Hautvast G, Ménard C.
PMID: 34861267
Radiother Oncol. 2021 Nov 30;166:154-161. doi: 10.1016/j.radonc.2021.11.026. Epub 2021 Nov 30.

BACKGROUND AND PURPOSE: Advances in high-dose-rate brachytherapy to treat prostate cancer hinge on improved accuracy in navigation and targeting while optimizing a streamlined workflow. Multimodal image registration and electromagnetic (EM) tracking are two technologies integrated into a prototype system...

Cite
Grajales D, Kadoury S, Shams R, et al. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021;166:154-161doi: 10.1016/j.radonc.2021.11.026.
Grajales, D., Kadoury, S., Shams, R., Barkati, M., Delouya, G., Béliveau-Nadeau, D., Nicolas, B., Le, W. T., Benhacene-Boudam, M. K., Juneau, D., DaSilva, J. N., Carrier, J. F., Hautvast, G., & Ménard, C. (2021). Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 166154-161. https://doi.org/10.1016/j.radonc.2021.11.026
Grajales, David, et al. "Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 166 (2021): 154-161. doi: https://doi.org/10.1016/j.radonc.2021.11.026
Grajales D, Kadoury S, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Le WT, Benhacene-Boudam MK, Juneau D, DaSilva JN, Carrier JF, Hautvast G, Ménard C. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021 Nov 30;166:154-161. doi: 10.1016/j.radonc.2021.11.026. Epub 2021 Nov 30. PMID: 34861267.
Copy Download .nbib Format: NLM
Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Grajales D, Kadoury S, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Le WT, Benhacene-Boudam MK, Juneau D, DaSilva JN, Carrier JF, Hautvast G, Ménard C.
PMID: 34861267
Radiother Oncol. 2021 Nov 30;166:154-161. doi: 10.1016/j.radonc.2021.11.026. Epub 2021 Nov 30.

BACKGROUND AND PURPOSE: Advances in high-dose-rate brachytherapy to treat prostate cancer hinge on improved accuracy in navigation and targeting while optimizing a streamlined workflow. Multimodal image registration and electromagnetic (EM) tracking are two technologies integrated into a prototype system...

Cite
Grajales D, Kadoury S, Shams R, et al. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021;166:154-161doi: 10.1016/j.radonc.2021.11.026.
Grajales, D., Kadoury, S., Shams, R., Barkati, M., Delouya, G., Béliveau-Nadeau, D., Nicolas, B., Le, W. T., Benhacene-Boudam, M. K., Juneau, D., DaSilva, J. N., Carrier, J. F., Hautvast, G., & Ménard, C. (2021). Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 166154-161. https://doi.org/10.1016/j.radonc.2021.11.026
Grajales, David, et al. "Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 166 (2021): 154-161. doi: https://doi.org/10.1016/j.radonc.2021.11.026
Grajales D, Kadoury S, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Le WT, Benhacene-Boudam MK, Juneau D, DaSilva JN, Carrier JF, Hautvast G, Ménard C. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021 Nov 30;166:154-161. doi: 10.1016/j.radonc.2021.11.026. Epub 2021 Nov 30. PMID: 34861267.
Copy Download .nbib Format: NLM
Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Grajales D, Kadoury S, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Le WT, Benhacene-Boudam MK, Juneau D, DaSilva JN, Carrier JF, Hautvast G, Ménard C.
PMID: 34861267
Radiother Oncol. 2021 Nov 30;166:154-161. doi: 10.1016/j.radonc.2021.11.026. Epub 2021 Nov 30.

BACKGROUND AND PURPOSE: Advances in high-dose-rate brachytherapy to treat prostate cancer hinge on improved accuracy in navigation and targeting while optimizing a streamlined workflow. Multimodal image registration and electromagnetic (EM) tracking are two technologies integrated into a prototype system...

Cite
Grajales D, Kadoury S, Shams R, et al. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021;166:154-161doi: 10.1016/j.radonc.2021.11.026.
Grajales, D., Kadoury, S., Shams, R., Barkati, M., Delouya, G., Béliveau-Nadeau, D., Nicolas, B., Le, W. T., Benhacene-Boudam, M. K., Juneau, D., DaSilva, J. N., Carrier, J. F., Hautvast, G., & Ménard, C. (2021). Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 166154-161. https://doi.org/10.1016/j.radonc.2021.11.026
Grajales, David, et al. "Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 166 (2021): 154-161. doi: https://doi.org/10.1016/j.radonc.2021.11.026
Grajales D, Kadoury S, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Le WT, Benhacene-Boudam MK, Juneau D, DaSilva JN, Carrier JF, Hautvast G, Ménard C. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021 Nov 30;166:154-161. doi: 10.1016/j.radonc.2021.11.026. Epub 2021 Nov 30. PMID: 34861267.
Copy Download .nbib Format: NLM
Technique for Robotic Stereotactic Irradiation of Choroidal Melanoma.

Cureus

Béliveau-Nadeau D, Callejo S, Roberge D.
PMID: 27226942
Cureus. 2016 Apr 21;8(4):e582. doi: 10.7759/cureus.582.

Radiotherapy has a long history in the organ-sparing management of choroidal melanoma. Joining plaque radiotherapy and proton irradiation, stereotactic robotic photon irradiation is a new tool in the radiation oncologist's armamentarium for ocular tumors. The non-coplanar fields with steep...

Cite
Béliveau-Nadeau D, Callejo S, Roberge D. Technique for Robotic Stereotactic Irradiation of Choroidal Melanoma. Cureus. 2016;8(4):e582doi: 10.7759/cureus.582.
Béliveau-Nadeau, D., Callejo, S., & Roberge, D. (2016). Technique for Robotic Stereotactic Irradiation of Choroidal Melanoma. Cureus, 8(4), e582. https://doi.org/10.7759/cureus.582
Béliveau-Nadeau, Dominic, et al. "Technique for Robotic Stereotactic Irradiation of Choroidal Melanoma." Cureus vol. 8,4 (2016): e582. doi: https://doi.org/10.7759/cureus.582
Béliveau-Nadeau D, Callejo S, Roberge D. Technique for Robotic Stereotactic Irradiation of Choroidal Melanoma. Cureus. 2016 Apr 21;8(4):e582. doi: 10.7759/cureus.582. PMID: 27226942; PMCID: PMC4876010.
Copy Download .nbib Format: NLM
Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Grajales D, Kadoury S, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Trung Le W, Benhacene-Boudam MK, Juneau D, DaSilva JN, Carrier JF, Hautvast G, Ménard C.
PMID: 34861267
Radiother Oncol. 2021 Nov 30; doi: 10.1016/j.radonc.2021.11.026. Epub 2021 Nov 30.

BACKGROUND AND PURPOSE: Advances in high-dose-rate brachytherapy to treat prostate cancer hinge on improved accuracy in navigation and targeting while optimizing a streamlined workflow. Multimodal image registration and electromagnetic (EM) tracking are two technologies integrated into a prototype system...

Cite
Grajales D, Kadoury S, Shams R, et al. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021;doi: 10.1016/j.radonc.2021.11.026.
Grajales, D., Kadoury, S., Shams, R., Barkati, M., Delouya, G., Béliveau-Nadeau, D., Nicolas, B., Trung Le, W., Benhacene-Boudam, M. K., Juneau, D., DaSilva, J. N., Carrier, J. F., Hautvast, G., & Ménard, C. (2021). Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, . https://doi.org/10.1016/j.radonc.2021.11.026
Grajales, David, et al. "Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. (2021). doi: https://doi.org/10.1016/j.radonc.2021.11.026
Grajales D, Kadoury S, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Trung Le W, Benhacene-Boudam MK, Juneau D, DaSilva JN, Carrier JF, Hautvast G, Ménard C. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021 Nov 30; doi: 10.1016/j.radonc.2021.11.026. Epub 2021 Nov 30. PMID: 34861267.
Copy Download .nbib Format: NLM
Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome?.

Journal of contemporary brachytherapy

Taussky D, Igidbashian L, Donath D, Béliveau-Nadeauv D, Larouche RX, Hervieux Y, Delouya G.
PMID: 28951748
J Contemp Brachytherapy. 2017 Aug;9(4):304-308. doi: 10.5114/jcb.2017.68467. Epub 2017 Jun 22.

PURPOSE: To analyze intraoperative (IO) dosimetry using transrectal ultrasound (TRUS), performed before and after prostate low-dose-rate brachytherapy (LDR-BT), and compare it to dosimetry performed 30 days following the LDR-BT implant (Day 30).MATERIAL AND METHODS: A total of 236 patients...

Cite
Taussky D, Igidbashian L, Donath D, et al. Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome?. J Contemp Brachytherapy. 2017;9(4):304-308doi: 10.5114/jcb.2017.68467.
Taussky, D., Igidbashian, L., Donath, D., Béliveau-Nadeauv, D., Larouche, R. X., Hervieux, Y., & Delouya, G. (2017). Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome?. Journal of contemporary brachytherapy, 9(4), 304-308. https://doi.org/10.5114/jcb.2017.68467
Taussky, Daniel, et al. "Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome?." Journal of contemporary brachytherapy vol. 9,4 (2017): 304-308. doi: https://doi.org/10.5114/jcb.2017.68467
Taussky D, Igidbashian L, Donath D, Béliveau-Nadeauv D, Larouche RX, Hervieux Y, Delouya G. Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome?. J Contemp Brachytherapy. 2017 Aug;9(4):304-308. doi: 10.5114/jcb.2017.68467. Epub 2017 Jun 22. PMID: 28951748; PMCID: PMC5611451.
Copy Download .nbib Format: NLM
Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Grajales D, Kadoury S, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Le WT, Benhacene-Boudam MK, Juneau D, DaSilva JN, Carrier JF, Hautvast G, Ménard C.
PMID: 34861267
Radiother Oncol. 2021 Nov 30;166:154-161. doi: 10.1016/j.radonc.2021.11.026. Epub 2021 Nov 30.

BACKGROUND AND PURPOSE: Advances in high-dose-rate brachytherapy to treat prostate cancer hinge on improved accuracy in navigation and targeting while optimizing a streamlined workflow. Multimodal image registration and electromagnetic (EM) tracking are two technologies integrated into a prototype system...

Cite
Grajales D, Kadoury S, Shams R, et al. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021;166:154-161doi: 10.1016/j.radonc.2021.11.026.
Grajales, D., Kadoury, S., Shams, R., Barkati, M., Delouya, G., Béliveau-Nadeau, D., Nicolas, B., Le, W. T., Benhacene-Boudam, M. K., Juneau, D., DaSilva, J. N., Carrier, J. F., Hautvast, G., & Ménard, C. (2021). Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 166154-161. https://doi.org/10.1016/j.radonc.2021.11.026
Grajales, David, et al. "Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 166 (2021): 154-161. doi: https://doi.org/10.1016/j.radonc.2021.11.026
Grajales D, Kadoury S, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Le WT, Benhacene-Boudam MK, Juneau D, DaSilva JN, Carrier JF, Hautvast G, Ménard C. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021 Nov 30;166:154-161. doi: 10.1016/j.radonc.2021.11.026. Epub 2021 Nov 30. PMID: 34861267.
Copy Download .nbib Format: NLM
Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical results.

Journal of contemporary brachytherapy

Lauche O, Delouya G, Taussky D, Menard C, Béliveau-Nadeau D, Hervieux Y, Larouche R, Barkati M.
PMID: 27257413
J Contemp Brachytherapy. 2016 Apr;8(2):104-9. doi: 10.5114/jcb.2016.59216. Epub 2016 Apr 14.

PURPOSE: To validate the feasibility of a single-fraction high-dose-rate brachytherapy (HDRBT) boost for prostate cancer using real-time transrectal ultrasound (TRUS) based planning.MATERIAL AND METHODS: From August 2012 to September 2015, 126 patients underwent a single-fraction HDRBT boost of 15...

Cite
Lauche O, Delouya G, Taussky D, et al. Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical results. J Contemp Brachytherapy. 2016;8(2):104-9doi: 10.5114/jcb.2016.59216.
Lauche, O., Delouya, G., Taussky, D., Menard, C., Béliveau-Nadeau, D., Hervieux, Y., Larouche, R., & Barkati, M. (2016). Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical results. Journal of contemporary brachytherapy, 8(2), 104-9. https://doi.org/10.5114/jcb.2016.59216
Lauche, Olivier, et al. "Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical results." Journal of contemporary brachytherapy vol. 8,2 (2016): 104-9. doi: https://doi.org/10.5114/jcb.2016.59216
Lauche O, Delouya G, Taussky D, Menard C, Béliveau-Nadeau D, Hervieux Y, Larouche R, Barkati M. Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical results. J Contemp Brachytherapy. 2016 Apr;8(2):104-9. doi: 10.5114/jcb.2016.59216. Epub 2016 Apr 14. PMID: 27257413; PMCID: PMC4873550.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries